<DOC>
	<DOCNO>NCT01101152</DOCNO>
	<brief_summary>DVS main metabolite antidepressant/anxiolytic medication Venlafaxine ( Effexor ) . Like parent compound , DVS antidepressant inhibit serotonin ( 5-HT ) norepinephrine ( NE ) reuptake . However , study date describe vivo potency drug monoamine reuptake . Consequently , appear essential determine potency DVS human subject use wide dose range order determine dose ( ) start inhibit 5-HT NE reuptake . The investigator interest learn whether gender difference dose study medication NE reuptake inhibition occur .</brief_summary>
	<brief_title>Effectiveness Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Female subject 18 40 year age , include oral contraceptive pill Male subject 1840 year age Written inform consent sign subject . Lifetime personal history diagnosis major depression accord DSMIV ( American Psychiatry Association , 1994 ) use MINI ( Sheehan et al . 1998 ) Blood pressure great 140/90 pulse rate great 90bpm Evidence significant physical illness contraindicating use DVS , find physical laboratory data obtain first week study Obvious mental retardation render response investigator unreliable Pregnancy , absence adequate contraceptive method . Concurrent use psychotropic medication antipsychotic , mood stabilizer regular use benzodiazepine . Participation clinical trial within 30 day entry current study Intolerance Desvenlafaxine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Antidepressant</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>desvenlafaxine succinate</keyword>
	<keyword>norepinephrine reuptake</keyword>
	<keyword>serotonin reuptake</keyword>
	<keyword>tyramine test</keyword>
</DOC>